(NASDAQ: BRKR) Bruker's forecast annual revenue growth rate of 4.51% is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 9.71%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.07%.
Bruker's revenue in 2026 is $3,438,900,000.On average, 18 Wall Street analysts forecast BRKR's revenue for 2026 to be $537,567,767,472, with the lowest BRKR revenue forecast at $507,635,362,104, and the highest BRKR revenue forecast at $566,436,584,832. On average, 16 Wall Street analysts forecast BRKR's revenue for 2027 to be $563,245,820,808, with the lowest BRKR revenue forecast at $519,182,889,048, and the highest BRKR revenue forecast at $600,167,518,800.
In 2028, BRKR is forecast to generate $600,015,577,656 in revenue, with the lowest revenue forecast at $550,634,705,856 and the highest revenue forecast at $644,838,215,136.